Why does screening start before symptoms appear?

Another post covers which organs diabetes damage reaches and at which vessel scale it collects. The question here is different: why does this buildup make you feel nothing, why doesn’t screening wait for a complaint? The three places share one trait: they stay quiet early on. The body gives no alarm; you feel fine.

The eye is the clearest case. When the vessels in the retina start leaking and clogging, vision holds a long while. Only an exam of the retina catches the change; the eye post covers how.

The kidney’s silence has another cause. The organ’s capacity sits well above need; while one part strains, the rest keeps carrying the work. So albumin leaking into the urine shows up before any complaint. The nerves’ silence comes from the loss’s slow pace; you often learn of fading sensation at an exam. With protective sensation erased, a sore on the foot doesn’t hurt; noticing it falls to looking, not feeling.

An early exam has another job: it leaves a baseline later exams are measured against. With no baseline in the record, slow change doesn’t look like change; back-of-the-eye and kidney values gain meaning only when read against their own history.

So why does screening’s start shift by diabetes type? The answer hides in when the illness began. Type 1 diabetes opens with an obvious picture: its first day is roughly known, and the counter runs from that day. Screening begins a few years later, because damage needs time to build. For those diagnosed in childhood the counter runs differently: the years before puberty don’t carry the buildup at the same pace, so the first exam opens late.

Type 2 diabetes settles in quietly; the diagnosis comes years later. That gap between settling and diagnosis leaves room for damage already begun. So screening opens on diagnosis day; in some people, eye involvement turns up at the very first exam.

What waiting for a symptom costs shows up right here. After fragile new vessels form in the retina, kidney filtering power drops, or the foot’s protective sensation is erased, the list of options shortens. Early on, though, the picture is still unsettled and open to changing direction. The quiet period is measured in years, not weeks; screening’s window is that wide.

What gets noticed in the late period is known: blurred vision or floating spots, numbness and tingling in the foot, stubborn ankle swelling. Listing these isn’t diagnosing; it’s showing what screening tries to leave behind.

Frequency is set person by person; no single schedule fits everyone. What doesn’t change is the logic. It’s the same reason the car’s oil gets checked before the engine makes a noise: once it does, the cheapest repair is already past.